Early Detection of Ovarian Cancer

被引:137
作者
Elias, Kevin M. [1 ]
Guo, Jing [2 ,3 ]
Bast, Robert C., Jr. [2 ]
机构
[1] Harvard Med Sch, Dana Farber Canc Inst, Brigham & Womens Hosp, Div Gynecol Oncol,Dept Obstet & Gynecol, 75 Francis St, Boston, MA 02115 USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, 1515 Holcombe Blvd, Houston, TX 77030 USA
[3] Tongji Univ, Shanghai Peoples Hosp 10, Dept Gynecol & Obstet, 301 Yanchang Rd, Shanghai 200072, Peoples R China
关键词
Ovarian cancer; Early detection; Screening; CA125; miRNA; TP53; Autoantibodies; ctDNA; METHYLATION-SPECIFIC PCR; SOMATIC TP53 MUTATIONS; UK COLLABORATIVE TRIAL; CELL-FREE DNA; PERITONEAL-FLUID; SCREENING TRIAL; ALGORITHM ROCA; TUMOR DNA; BREAST; BLOOD;
D O I
10.1016/j.hoc.2018.07.003
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Early detection of ovarian cancer could reduce mortality by 10% to 30%. Effective screening requires high sensitivity (>75%) and extremely high specificity (99.7%). Clinical trials suggest the best specificity is achieved with 2-stage strategies in which increasing serum CA125 level triggers transvaginal sonography to detect a malignant pelvic mass, although evidence for such approaches improving overall survival has been limited. Screening may be improved by combining CA125 with novel biomarkers, such as autoantibodies, circulating tumor DNA, or microRNAs. In order to detect premetastatic ovarian cancers originating in the distal fallopian tube, more sensitive approaches to diagnostic imaging are required.
引用
收藏
页码:903 / +
页数:13
相关论文
共 61 条
[1]   Imaging of Her2-targeted magnetic nanoparticles for breast cancer detection: comparison of SQUID-detected magnetic relaxometry and MRI [J].
Adolphi, Natalie L. ;
Butler, Kimberly S. ;
Lovato, Debbie M. ;
Tessier, T. E. ;
Trujillo, Jason E. ;
Hathaway, Helen J. ;
Fegan, Danielle L. ;
Monson, Todd C. ;
Stevens, Tyler E. ;
Huber, Dale L. ;
Ramu, Jaivijay ;
Milne, Michelle L. ;
Altobelli, Stephen A. ;
Bryant, Howard C. ;
Larson, Richard S. ;
Flynn, Edward R. .
CONTRAST MEDIA & MOLECULAR IMAGING, 2012, 7 (03) :308-319
[2]   Assessment of lead-time bias in estimates of relative survival for breast cancer [J].
Andersson, Therese M. -L. ;
Rutherford, Mark J. ;
Humphreys, Keith .
CANCER EPIDEMIOLOGY, 2017, 46 :50-56
[3]   MicroRNAs: Target Recognition and Regulatory Functions [J].
Bartel, David P. .
CELL, 2009, 136 (02) :215-233
[4]   A RADIOIMMUNOASSAY USING A MONOCLONAL-ANTIBODY TO MONITOR THE COURSE OF EPITHELIAL OVARIAN-CANCER [J].
BAST, RC ;
KLUG, TL ;
STJOHN, E ;
JENISON, E ;
NILOFF, JM ;
LAZARUS, H ;
BERKOWITZ, RS ;
LEAVITT, T ;
GRIFFITHS, CT ;
PARKER, L ;
ZURAWSKI, VR ;
KNAPP, RC .
NEW ENGLAND JOURNAL OF MEDICINE, 1983, 309 (15) :883-887
[5]   Detection of Cancer DNA in Plasma of Patients with Early-Stage Breast Cancer [J].
Beaver, Julia A. ;
Jelovac, Danijela ;
Balukrishna, Sasidharan ;
Cochran, Rory L. ;
Croessmann, Sarah ;
Zabransky, Daniel J. ;
Wong, Hong Yuen ;
Toro, Patricia Valda ;
Cidado, Justin ;
Blair, Brian G. ;
Chu, David ;
Burns, Timothy ;
Higgins, Michaela J. ;
Stearns, Vered ;
Jacobs, Lisa ;
Habibi, Mehran ;
Lange, Julie ;
Hurley, Paula J. ;
Lauring, Josh ;
VanDenBerg, Dustin A. ;
Kessler, Jill ;
Jeter, Stacie ;
Samuels, Michael L. ;
Maar, Dianna ;
Cope, Leslie ;
Cimino-Mathews, Ashley ;
Argani, Pedram ;
Wolff, Antonio C. ;
Park, Ben Ho .
CLINICAL CANCER RESEARCH, 2014, 20 (10) :2643-2650
[6]   Integrated genomic analyses of ovarian carcinoma [J].
Bell, D. ;
Berchuck, A. ;
Birrer, M. ;
Chien, J. ;
Cramer, D. W. ;
Dao, F. ;
Dhir, R. ;
DiSaia, P. ;
Gabra, H. ;
Glenn, P. ;
Godwin, A. K. ;
Gross, J. ;
Hartmann, L. ;
Huang, M. ;
Huntsman, D. G. ;
Iacocca, M. ;
Imielinski, M. ;
Kalloger, S. ;
Karlan, B. Y. ;
Levine, D. A. ;
Mills, G. B. ;
Morrison, C. ;
Mutch, D. ;
Olvera, N. ;
Orsulic, S. ;
Park, K. ;
Petrelli, N. ;
Rabeno, B. ;
Rader, J. S. ;
Sikic, B. I. ;
Smith-McCune, K. ;
Sood, A. K. ;
Bowtell, D. ;
Penny, R. ;
Testa, J. R. ;
Chang, K. ;
Dinh, H. H. ;
Drummond, J. A. ;
Fowler, G. ;
Gunaratne, P. ;
Hawes, A. C. ;
Kovar, C. L. ;
Lewis, L. R. ;
Morgan, M. B. ;
Newsham, I. F. ;
Santibanez, J. ;
Reid, J. G. ;
Trevino, L. R. ;
Wu, Y. -Q. ;
Wang, M. .
NATURE, 2011, 474 (7353) :609-615
[7]   Ovarian cancer screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening trial: Findings from the initial screen of a randomized trial [J].
Buys, SS ;
Partridge, E ;
Greene, MH ;
Prorok, PC ;
Reding, D ;
Riley, TL ;
Hartge, P ;
Fagerstrom, RM ;
Chia, D ;
Izmirlian, G ;
Fouad, M ;
Ragard, LR ;
Johnson, CC ;
Gohagan, JK .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2005, 193 (05) :1630-1639
[8]   Detection and localization of surgically resectable cancers with a multi-analyte blood test [J].
Cohen, Joshua D. ;
Li, Lu ;
Wang, Yuxuan ;
Thoburn, Christopher ;
Afsari, Bahman ;
Danilova, Ludmila ;
Douville, Christopher ;
Javed, Ammar A. ;
Wong, Fay ;
Mattox, Austin ;
Hruban, Ralph. H. ;
Wolfgang, Christopher L. ;
Goggins, Michael G. ;
Dal Molin, Marco ;
Wang, Tian-Li ;
Roden, Richard ;
Klein, Alison P. ;
Ptak, Janine ;
Dobbyn, Lisa ;
Schaefer, Joy ;
Silliman, Natalie ;
Popoli, Maria ;
Vogelstein, Joshua T. ;
Browne, James D. ;
Schoen, Robert E. ;
Brand, Randall E. ;
Tie, Jeanne ;
Gibbs, Peter ;
Wong, Hui-Li ;
Mansfield, Aaron S. ;
Jen, Jin ;
Hanash, Samir M. ;
Falconi, Massimo ;
Allen, Peter J. ;
Zhou, Shibin ;
Bettegowda, Chetan ;
Diaz, Luis A., Jr. ;
Tomasetti, Cristian ;
Kinzler, Kenneth W. ;
Vogelstein, Bert ;
Lennon, Anne Marie ;
Papadopoulos, Nickolas .
SCIENCE, 2018, 359 (6378) :926-+
[9]   Ovarian Cancer Biomarker Performance in Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial Specimens [J].
Cramer, Daniel W. ;
Bast, Robert C., Jr. ;
Berg, Christine D. ;
Diamandis, Eleftherios P. ;
Godwin, Andrew K. ;
Hartge, Patricia ;
Lokshin, Anna E. ;
Lu, Karen H. ;
McIntosh, Martin W. ;
Mor, Gil ;
Patriotis, Christos ;
Pinsky, Paul F. ;
Thornquist, Mark D. ;
Scholler, Nathalie ;
Skates, Steven J. ;
Sluss, Patrick M. ;
Srivastava, Sudhir ;
Ward, David C. ;
Zhang, Zhen ;
Zhu, Claire S. ;
Urban, Nicole .
CANCER PREVENTION RESEARCH, 2011, 4 (03) :365-374
[10]  
Critchley HOD, 2004, HEALTH TECHNOL ASSES, V8, P1